(Q43875498)

27 November 2017

title

MMR deficiency is common in high-grade endometrioid carcinomas and is associated with an unfavorable outcome (English)

1 reference

27 November 2017

8

1 reference

27 November 2017

Gregg S Nelson

1

1 reference

27 November 2017

Aaron Pink

2

1 reference

27 November 2017

Sandra Lee

3

1 reference

27 November 2017

Guangming Han

4

1 reference

27 November 2017

Don Morris

5

1 reference

27 November 2017

Travis Ogilvie

6

1 reference

27 November 2017

Máire A Duggan

7

1 reference

27 November 2017

language of work or name

English

0 references

publication date

11 August 2013

1 reference

27 November 2017

1 reference

27 November 2017

volume

131

1 reference

27 November 2017

issue

2

1 reference

27 November 2017

page(s)

309-314

1 reference

27 November 2017

cites work

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.003

Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.003

Poor interobserver reproducibility in the diagnosis of high-grade endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.003

Histotype-genotype correlation in 36 high-grade endometrial carcinomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.003

Reproducibility of histological cell type in high-grade endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.003

Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.003

Serous endometrial cancers that mimic endometrioid adenocarcinomas: a clinicopathologic and immunohistochemical study of a group of problematic cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.003

Histologic and immunohistochemical decision-making in endometrial adenocarcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.003

High-grade endometrial carcinoma: serous and grade 3 endometrioid carcinomas have different immunophenotypes and outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.003

Integrated genomic characterization of endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.003

Identifying Lynch syndrome in patients with endometrial carcinoma: shortcomings of morphologic and clinical schemas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.003

Lynch syndrome (hereditary non-polyposis colorectal cancer) and endometrial carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.003

Systematic review of microsatellite instability and colorectal cancer prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.003

DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.003

Clinicopathologic significance of defective DNA mismatch repair in endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.003

Prognostic value of microsatellite instability (MSI) and PTEN expression in women with endometrial cancer: results from studies of the NCIC Clinical Trials Group (NCIC CTG).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.003

Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/β-catenin and P53 pathway activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.003

Molecular pathology of endometrial carcinoma: practical aspects from the diagnostic and therapeutic viewpoints

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.003

Microsatellite Instability and Epigenetic Inactivation ofMLH1and Outcome of Patients With Endometrial Carcinomas of the Endometrioid Type

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.003

Microsatellite instability in endometrioid type endometrial adenocarcinoma is associated with poor prognostic indicators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.003

Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.003

Use of mutation profiles to refine the classification of endometrial carcinomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.003

Quantification of ER/PR expression in ovarian low-grade serous carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.003

Strategies for distinguishing low-grade endometrioid and serous carcinomas of endometrium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.003

BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.003

Prevalence of loss of expression of DNA mismatch repair proteins in primary epithelial ovarian tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.003

Are women with endocervical adenocarcinoma at risk for lynch syndrome? Evaluation of 101 cases including unusual subtypes and lower uterine segment tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.003

Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.003

The relationship between microsatellite instability and PTEN gene mutations in endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.003

High-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.003

Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.003

Next-generation biomarkers based on 100-parameter functional super-resolution microscopy TIS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.003

10.1016/J.YGYNO.2013.08.003

7 January 2021

Identifiers

DOI

1 reference

27 November 2017

1 reference